BUDGET IMPACT ANALYSIS (BIA) OF CABAZITAXEL INTRODUCTION IN TREATMENT OF METASTATIC HORMONE-REFRACTORY PROSTATE CANCER (MHRPC) IN RUSSIAN FEDERATION

被引：0
|
作者：
Yagudina, R. [1 ]
Kulikov, A. [1 ]
Kogon, L. [2 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
[2] FGBU NCESMP Minist Hlth Russia, Moscow, Russia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.640
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [41] New progress in treatment of hormone-refractory prostate cancer
    Ahmad, K
    LANCET ONCOLOGY, 2004, 5 (12): : 706 - 706
  • [42] Oral chemotherapy in the treatment of hormone-refractory prostate cancer
    Pienta, KJ
    Kamradt, JM
    Smith, DC
    DRUGS, 1999, 58 (Suppl 3) : 127 - 131
  • [43] Treatment of patients with hormone-refractory prostate cancer with mitoxantrone
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 95 - 95
  • [44] Oral Chemotherapy in the Treatment of Hormone-Refractory Prostate Cancer
    Kenneth J. Pienta
    Jeffrey M. Kamradt
    David C. Smith
    Drugs, 1999, 58 : 127 - 131
  • [45] Current topics in the treatment of hormone-refractory prostate cancer
    Iversen, P
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 3 - 8
  • [46] A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer
    Collins, R.
    Trowman, R.
    Norman, G.
    Light, K.
    Birtle, A.
    Fenwick, E.
    Palmer, S.
    Riemsma, R.
    BRITISH JOURNAL OF CANCER, 2006, 95 (04) : 457 - 462
  • [47] Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer
    Smith, Matthew R.
    Cook, Richard J.
    Coleman, Robert
    Brown, Janet
    Lipton, Allan
    Major, Pierre
    Hei, Yong Jiang
    Saad, Fred
    UROLOGY, 2007, 70 (02) : 315 - 319
  • [48] Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer
    Vordos, D
    Paule, B
    Vacherot, F
    Allory, Y
    Salomon, L
    Hoznek, A
    Yiou, R
    Chopin, D
    Abbou, CC
    de la Taille, A
    BJU INTERNATIONAL, 2004, 94 (04) : 524 - 527
  • [49] Phase II study of topotecan in metastatic hormone-refractory prostate cancer
    Hudes, GR
    Kosierowski, R
    Greenberg, R
    Ramsey, HE
    Fox, SC
    Ozols, RF
    McAleer, CA
    Giantonio, BJ
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (03) : 235 - 240
  • [50] The current role of chemotherapy in metastatic hormone-refractory prostate cancer - Discussion
    Smith, MR
    Petrylak, DP
    Carducci, MA
    Thompson, IM
    UROLOGY, 2005, 65 (5A) : 7 - 8
12345